Food Addiction Clinical Treatment Program
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Apr 30, 2020
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
To establish the feasibility of recruiting, enrolling, and treating individuals who meet criteria for FA in a group behavioral intervention for 16 weeks. Data from the current study will be used for the purposes of further exploration of the FACT program in a larger randomized controlled trial. We hypothesize the study will demonstrate the feasibility of evaluating this treatment in future studies
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 25
- • BMI \>25
- • YFAS \> 6/11 (severe range)
- • willing to commit to a 16 week group therapy program from 4 - 5:30 pm on Thursdays in Winston-Salem, NC
- • English speaking
- Exclusion Criteria:
- • Current participation in professional weight loss program and unwillingness to suspend it for 16 weeks during treatment
- • obesity medications with exception of diabetes medication with weight loss benefit (ie metformin),
- • current nicotine use or substance use disorder (based on meeting the clinical cutoff for the Alcohol Use Disorders Identification Test and/or Cannabis Use Disorder Identification Test
- • history of weight loss surgery,
- • current/history of severe mental illness (\> 3 psychiatric hospitalizations since age 18,
- • schizoaffective disorder, bipolar disorder, psychotic disorder, or personality disorder),
- • current/history of lithium, abilify, saphris, vraylor, clozaril, latuda, zyprexa, seroquel, risperdal, or Geodon,
- • current pregnancy or breastfeeding,
- • prior diagnosis of anorexia nervosa, diagnosis of bulimia nervosa in the last 5 years,
- • high currents rates of restrictive eating disorder symptoms based on the Eating Disorder Diagnosis Scale (EDDS; (i.e., any endorsement of vomiting or laxative/diuretic use to manage weight and endorsement of fasting or excessive exercise more than 2 or 3 times a week)
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Shenelle Edwards-Hampton, PhD
Principal Investigator
Wake Forest Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials